What we do

At Gresham House Ventures, we look to work with exceptional entrepreneurs. We’ve been investing in high-growth businesses together for over twelve years and we specialise in scaling software and digitally-driven businesses in the healthcare, consumer and services sectors

Investments

Track record

Investment size

Capital to invest

See our approach

Our portfolio

Metrion Biosciences

Contract research organisation providing ion channel services to the drug discovery market

Countingup

The business current account with built-in accounting software

RevLifter

Ecommerce deal personalisation platform

eConsult

Online consulting provider to the NHS

Clarilis

Legal drafting automation platform

Yappy

Personalised pet products

Rezatec

Big Data geoanalytics

Glisser

Glisser is the leading live audience engagement and meeting analytics platform

IWP

IWP is a nationwide network of independent financial advisors and wealth managers, providing support services and taking a financial stake in its members

See our portfolio

What Gresham House Ventures investees say

This new investment is a key part of Metrion’s strategic development, enabling the Company to expand its laboratories, provide enhanced services and invest more extensively in US business development. We thank Gresham House for the confidence they have shown in the Metrion team.

Keith McCullough, Chairman, Metrion Biosciences

Gresham House were the clear choice here given Henry Alty and James Hendry’s in-depth knowledge of the LegalTech space and excellent insight. The Gresham House team also share our vision for the development of the Clarilis platform going forward.

James Quinn, co-founder and CEO, Clarilis

Their understanding of what we were doing in this market and how it was developing made it a very natural fit to work with Gresham House.

David Poole, Symphony, Co-Founder & CEO